News Feed
News Feed
News Feed
POSITIVE DATA PRESENTED ON PIERIS PHARMACEUTICALS’ INHALED ASTHMA PROGRAM AT ERS AND COMPANY STRENGTHENS MANAGEMENT TEAM
PRECLINICAL DATA ON THE IL-4 RECEPTOR ANTAGONIST PRS-060 PRESENTED AT THE EUROPEAN RESPIRATORY SOCIETY CONFERENCE; MARY FITZGERALD, PH.D., TO LEAD PIERIS RESPIRATORY DRUG DEVELOPMENT PROGRAM […]
News Feed
Code Rebel Completes iRAPP Beta Release for Mac OS X El Capitan 10.11 in Record Time
Code Rebel Corp. (NASDAQ: CDRB) […]
News Feed
Pieris Pharmaceuticals Presents Positive Preclinical Data on Lead Bispecific Immuno-Oncology Program
Tumor-targeting CD137/HER2 Bispecifics Exhibit Desired Drug-Like Properties and Tumor-Dependent T Cell Activation […]
News Feed
At the Forefront of Immunology: WSA Interviews Immune Pharma and TapImmune
Wall Street Analyzer’s CEO Interview Series […]
News Feed
News Feed
News Feed
Immune Pharmaceuticals Secures Funding of up to $21.5 Million from Institutional Investors
Up to $9.5 Million in Debt Financing and $12 Million in Equity Financing.
Company to Advance its Immuno-Dermatology and Inflammatory Bowel Disease Product Candidates
Lead Compound Bertilimumab, First-in-Class Autoimmune Therapy, a Priority
[…]
News Feed
News Feed
Pacific Energy Development Announces Commencement of Drilling This Week on Seven New Wattenberg Wells
Will Also Participate in Additional Wattenberg Well […]